Astera Labs Inc. (ALAB) concluded trading on Thursday at a closing price of $70.30, with 3.54 million shares of worth about $248.9 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -1.80% during that period and on October 24, 2024 the price saw a gain of about 3.69%. Currently the company’s common shares owned by public are about 155.47M shares, out of which, 113.06M shares are available for trading.
Stock saw a price change of 6.53% in past 5 days and over the past one month there was a price change of 34.93%. Over the period of past 52 weeks, stock dropped to lowest price of $36.22 but also hit the highest price of $95.21 during that period. The average intraday trading volume for Astera Labs Inc. shares is 3.48 million. The stock is currently trading 16.47% above its 20-day simple moving average (SMA20), while that difference is up 39.21% for SMA50 and it goes to 18.82% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Astera Labs Inc. (NASDAQ: ALAB) currently have 155.47M outstanding shares and institutions hold larger chunk of about 32.19% of that.
The stock has a current market capitalization of $11.01B. It has posted earnings per share of -$0.57 in the same period. It has Quick Ratio of 13.46 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ALAB, volatility over the week remained 4.57% while standing at 5.60% over the month.
Stock’s fiscal year EPS is expected to rise by 609.23% while it is estimated to increase by 47.56% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Morgan Stanley on September 04, 2024 offering an Overweight rating for the stock and assigned a target price of $55 to it. Coverage by Evercore ISI stated Astera Labs Inc. (ALAB) stock as an Outperform in their note to investors on April 16, 2024, suggesting a price target of $100 for the stock. On April 15, 2024, Stifel Initiated their recommendations, while on April 15, 2024, ROTH MKM Initiated their ratings for the stock with a price target of $85. Stock get a Buy rating from Needham on April 15, 2024.
